New England Cancer Specialists’ Post

In this discussion, Drs. Roger Goldberg, Karl Csaky, MD, PhD, & Eleonora (Nora) Lad, examine evolving trial data on functional & anatomic outcomes in GA & analyze how targeting different components of the complement pathway may lead to distinct therapeutic outcomes. View here: https://lnkd.in/eypify-x

CASE STUDY: An example of how large-scale generation of iPSC-derived models can be streamlined to success. This study by Karin Langenberg shows how we developed a scalable process for skeletal muscle cells, highlighting a cost-efficient approach and the use of high-content imaging for quality assessment. Enhance your understanding of iPSC technology and its applications to advance therapeutic research. Download the full case study here: https://lnkd.in/dpBqEsBQ #Ncardia #iPSC #CaseStudy

Kicking off Multiomics in Precision Medicine 2024 with an opening keynote from Michael Snyder! #multiomics2024

What were the main scientific highlights and key learnings from #EuroPCR 2024, and what should you know about impact on practice? In this short session replay, Davide Capodanno summarises his key takeaways from this year's Course ➡ https://lnkd.in/d5XsMnQW (open access). Nieves Gonzalo Nicolas Dumonteil Thomas Cuisset #interventionalcardiology #clinicaltrials #latebreakingscience #trialupdates

Are #flashbackfridays still a thing? Seems timely to have this "making cells talk" article pop up from my Beth Israel Deaconess Medical Center days with Vasilis Toxavidis & John Tigges! Now instead of making cells talk, I spend my days helping people listen to what their cells are saying. 😉 What secrets are YOUR cells looking to share? #flowcytometry #nocellsleftbehind #singlecellanalysis #multiomics #scRNAseq #transcriptomics

A day to remember how important research is for science and, even more so, for people’s lives. Advocating for more clinical trials and safe data that can improve people’s lives and bring cures to rare diseases. #duchennemusculardystrophy #beckermusculardystrophy

Discover how scientists are changing the future of medicine by leveraging the power of human placental cells, as KCSA client and CEO of Celularity Inc., Dr. Robert Hariri, MD, PhD, joins Leyla Gulen for an exclusive interview on Global Market Bulletin to discuss the latest breakthroughs in cellular medicine: https://lnkd.in/enrrFXvh #CellularMedicine #RegenerativeMedicine

Promising results presented at #RSNA2023 on combined multiparametric ultrasound markers to identify NAFLD patients with advanced fibrosis using Aplio i800 / Prism Edition. Katsutoshi Sugimoto, MD, PhD, from Tokyo Medical University in Japan discussed how ultrasound can serve as a noninvasive and accurate tool to assess liver fibrosis. Read the full article here: https://lnkd.in/g2Xt6Kg7

Check out the highlights from webinar we hosted with Dr. Neil Sadick & Dr. Sanjay Batra below!

Check out this introductory video as part of an In Focus feature sponsored by PromoCell. We explore angiogenesis as a strategy for tissue repair and regeneration and delve further into the challenges of translating this research to a clinical setting >>> https://bit.ly/4cczfAP